Home524669 • BOM
add
Hester Biosciences Ltd
Previous close
₹1,529.65
Year range
₹1,246.75 - ₹2,347.70
Market cap
13.21B INR
Avg Volume
199.00
P/E ratio
40.49
Dividend yield
0.46%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 774.15M | 8.99% |
Operating expense | 433.25M | 1.17% |
Net income | 87.65M | -24.84% |
Net profit margin | 11.32 | -31.06% |
Earnings per share | — | — |
EBITDA | 174.66M | 36.50% |
Effective tax rate | 31.16% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 79.38M | -52.72% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 3.51B | — |
Shares outstanding | 8.01M | — |
Price to book | 3.88 | — |
Return on assets | — | — |
Return on capital | 5.92% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 87.65M | -24.84% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Hester Biosciences Limited is a publicly traded Indian animal and poultry vaccines manufacturing company, headquartered in Ahmedabad. Hester has plants situated in Gujarat and Nepal. Hester has a 30% share of the poultry vaccines market in India, making it the country's second largest poultry vaccine manufacturer. Hester is also the first commercial manufacturer of goat pox vaccine in India and manufactures PPR vaccines from both, Nigerian and Sungri strains. Wikipedia
Founded
1983
Website
Employees
562
